Associations of hormonal contraceptives and infertility medications on the risk of venous thromboembolism, ischemic stroke, and cardiovascular disease in women.


Journal

Journal of investigative medicine : the official publication of the American Federation for Clinical Research
ISSN: 1708-8267
Titre abrégé: J Investig Med
Pays: England
ID NLM: 9501229

Informations de publication

Date de publication:
04 2019
Historique:
accepted: 04 11 2018
pubmed: 28 11 2018
medline: 10 7 2020
entrez: 28 11 2018
Statut: ppublish

Résumé

The purpose of this study was to examine the relations of hormonal contraceptives and infertility drugs with the risk of venous thromboembolism (VTE), deep vein thrombosis (DVT), pulmonary embolism (PE), ischemic stroke, and cardiovascular disease. The Taiwan National Health Institute Research Database was searched for women who had taken hormonal contraceptives or infertility medications from 2000 to 2010. The two groups were age and index date matched with controls (1:4 ratios). Cox regression analysis was used to examine the risks of VTE, DTE, PE, ischemic stroke, and cardiovascular disease. A total of 32,067 women were included in the hormonal contraceptives group and 4710 in the infertility medications group (matched controls: 127,872 and 18,840, respectively). After adjustment for age, comorbidities, and other confounders, the contraceptives group had a higher risk of VTE (adjusted HR 1.14, 95% CI 1.004 to 1.30) and cardiovascular disease (adjusted HR 1.30, 95% CI 1.26 to 1.34), and lower risk of ischemic stroke (adjusted HR 0.90, 95% CI 0.86 to 0.95). The infertility medications group had a higher risk of VTE (adjusted HR 1.996, 95% CI 1.41 to 2.72) and DVT (adjusted HR 1.86, 95% CI 1.31 to 2.63), and lower risk of ischemic stroke (adjusted HR 0.82, 95% CI 0.68 to 0.99) and cardiovascular disease (adjusted HR 0.83, 95% CI 0.74 to 0.94). Hormonal contraceptives and infertility medications appear to lower the risk of ischemic stroke and increase the risk of VTE; however, their effect on the risk of other types of cardiovascular events varies.

Identifiants

pubmed: 30478156
pii: jim-2018-000750
doi: 10.1136/jim-2018-000750
doi:

Substances chimiques

Contraceptive Agents 0
Fertility Agents 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

729-735

Informations de copyright

© American Federation for Medical Research 2019. No commercial re-use. See rights and permissions. Published by BMJ.

Déclaration de conflit d'intérêts

Competing interests: None declared.

Auteurs

Shu-Qi Ge (SQ)

Department of Infertility and Sexual Medicine, the Third Affiliated Hospital, Sun-Yet Sen University, Guangzhou, People's Republic of China.

Xin Tao (X)

Center for Reproductive Medicine, the Third Affiliated Hospital, Sun-Yet Sen University, Guangzhou, People's Republic of China.

Li-Si Cai (LS)

Center for Reproductive Medicine, the Third Affiliated Hospital, Sun-Yet Sen University, Guangzhou, People's Republic of China.

Xuan-Ying Deng (XY)

Center for Reproductive Medicine, the Third Affiliated Hospital, Sun-Yet Sen University, Guangzhou, People's Republic of China.

Muh-Fa Hwang (MF)

Department of Obstetrics and Gynecology, Min-Sheng General Hospital, Taoyuan, Taiwan.

Chiung-Lang Wang (CL)

Department of Obstetrics and Gynecology, Min-Sheng General Hospital, Taoyuan, Taiwan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH